Know Your Tools: Hormonal Diagnostics for Fertility, PCOS & Menopause

11 June 2025

Updated on 26 June 2025

Held on Wednesday, June 25, 2025 at 15:00 BST / 16:00 CEST / 10:00 EDT / 7:00 PDT

What's the webinar about?

This webinar explores key aspects of hormonal diagnostics in female reproductive health, focusing on practical approaches to evaluating irregular cycles, diagnosing PCOS, and assessing ovarian reserve and menopause. It highlights the clinical use of key biomarkers such as AMH and FSH, and how hormonal testing supports decision-making in women’s health.

The session also introduces Medix Biochemica’s hormone antibody and antigen portfolio, designed to support the development of reliable IVD solutions in reproductive diagnostics.

It is intended for clinicians, gynecologists, endocrinologists, and IVD professionals involved in developing diagnostic solutions for women’s health.

If you would like to subscribe to future Medix Biochemica Webinars simply click the link below

Subscribe to Future Webinars

Discussion points:

Hormonal Diagnostics in Women’s Health

Evaluation of irregular menstrual cycles
Hormonal measurements in PCOS diagnostics
AMH in PCOS diagnostics
How to measure gonadal function and ovarian reserve
Evaluation of menopause
Medix Biochemica’s hormone antibody and antigen portfolio for IVD test development

Key take aways:

Evaluation of irregular cycles is important to identify health impairments in women
The PCOS diagnostic algorithm includes serum measurements to evaluate hyperandrogenism and polycystic ovarian morphology
Ovarian reserve and menopausal status may be supported by serum AMH and FSH measurements
Medix Biochemica’s hormone antibodies and antigens support the development of reliable IVD tools for reproductive health diagnostics

If you watched our webinar then please let us know how we did!

Take our Survey

Contact us for more information!

Our speakers and host for the webinar

Terhi Piltonen

Prof. Terhi Piltonen

Professor of Obstetrics and Gynecology, University of Oulu, Finland

Terhi Piltonen, MD, PhD, is a professor of Obstetrics and Gynecology at Oulu University, Finland. She leads a research team focused on polycystic ovary syndrome (PCOS), endometrial function, and hormonal contraceptives with translational approach utilizing national register data, birth cohorts, clinical trials and animal work. Prof. Piltonen is a past associate editor for European Journal of Endocrinology and Fertility and Sterility, Co-Editor in Chief of Seminars in Reproductive Medicine. Currently she is the president of the Androgen Excess and PCOS Society and scientific chair and board member of the Nordic Federation of Obstetrics and Gynecology (NFOG). She has published over 200 publications with an H-index of 51.

Dr. Maria Voutilainen

Dr. Maria Voutilainen

Global Product Manager, Medix Biochemica

Dr. Maria Voutilainen is the Global Product Manager at Medix Biochemica, where she oversees the Neurology, Hormones, Drugs of Abuse, Veterinary, and Therapeutic Drug Monitoring portfolios. In her current position, she is responsible for the strategic planning, development, and commercialization of these product lines, ensuring they meet the highest standards of quality and efficacy.Maria has extensive experience in the private bioscience sector. She has worked with laboratory instruments, consumables, and in vitro diagnostic (IVD) assays across various stages of the product life cycle, from initial research and development to market launch and post-market support. Maria holds a PhD in Genetics from the University of Helsinki. She is dedicated to science communication and promoting partnerships and dialogue between the private sector and academic institutions.

Anthony Austin

Global Marketing Manager, Medix Biochemica

Anthony is the Global Marketing Manager for Medix Biochemica, starting in 2022. He enters this role after 15 years holding various science focused responsibilities in R&D, Manufacturing, Analytical and Product Management. Prior to Medix Biochemica, he worked in academic labs studying bone metabolism and genetic diseases affecting white blood cells and their ability to fight infections.